• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Biomarkers in the era of individualized medicine.个体化医疗时代的生物标志物。
J Thorac Dis. 2017 Jun;9(6):1453-1454. doi: 10.21037/jtd.2017.05.55.
2
Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.利用基因表达和癌症生物标志物为个性化医疗时代铺平道路。
Genomics Proteomics Bioinformatics. 2017 Aug;15(4):220-235. doi: 10.1016/j.gpb.2016.11.005. Epub 2017 Aug 13.
3
[Evidence-based medicine and individualized health care].[循证医学与个性化医疗保健]
Zhong Xi Yi Jie He Xue Bao. 2009 Jun;7(6):505-8. doi: 10.3736/jcim20090602.
4
[The 42nd Scientific Meeting: Perspectives of Internal Medicine; Considerations to treatment and care of cancer by internists in the era of increasing cancer mortality; 3. Current Status of Diagnosis and Treatment of Cancer; 3) Cancer biomarker and individualized therapy].[第42届科学会议：内科医学展望；癌症死亡率上升时代内科医生对癌症治疗与护理的思考；3. 癌症诊断与治疗现状；3）癌症生物标志物与个体化治疗]
Nihon Naika Gakkai Zasshi. 2015 Mar 10;104(3):449-55. doi: 10.2169/naika.104.449.
5
Exercise testing in heart failure: a contemporary discussion in an era of novel diagnostic techniques and biomarkers.心力衰竭中的运动试验：在新型诊断技术和生物标志物时代的当代讨论
Curr Opin Cardiol. 2018 Mar;33(2):217-224. doi: 10.1097/HCO.0000000000000490.
6
[Personalized medicine in oncology: one drug, one biomarker].肿瘤学中的个性化医疗：一种药物，一种生物标志物
An R Acad Nac Med (Madr). 2012;129(1):371-85.
7
Biomarkers in drug development and regulation: a paradigm for clinical implementation of personalized medicine.生物标志物在药物研发和监管中的作用：个性化医学临床实施的范例。
Biomark Med. 2011 Dec;5(6):705-13. doi: 10.2217/bmm.11.90.
8
miRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine?miRNAs 作为心肌梗死的生物标志物：迈向个体化医学的一步？
Trends Mol Med. 2014 Dec;20(12):716-25. doi: 10.1016/j.molmed.2014.10.006. Epub 2014 Nov 5.
9
Incorporating pattern identification of Chinese medicine into precision medicine: An integrative model for individualized medicine.将中医模式识别融入精准医学：个性化医疗的整合模型。
Chin J Integr Med. 2015 Nov;21(11):807-10. doi: 10.1007/s11655-015-2058-9. Epub 2015 Oct 31.
10
Individualized Treatment Strategy for Depressive Disorder.个体化抑郁障碍治疗策略。
Adv Exp Med Biol. 2019;1180:219-232. doi: 10.1007/978-981-32-9271-0_12.

本文引用的文献

1
The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas.肺腺癌中表皮生长因子受体（EGFR）突变与诊断时分期的关联
PLoS One. 2016 Nov 18;11(11):e0166821. doi: 10.1371/journal.pone.0166821. eCollection 2016.
2
Epidermal Growth Factor Receptor Mutations and Prognosis in Pathologic N1-N2 Pulmonary Adenocarcinoma.病理N1-N2期肺腺癌中表皮生长因子受体突变与预后
Ann Thorac Surg. 2016 Dec;102(6):1821-1828. doi: 10.1016/j.athoracsur.2016.06.001. Epub 2016 Aug 20.
3
Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer.表皮生长因子受体突变状态对手术切除的非小细胞肺癌患者复发后生存的影响。
Eur J Cardiothorac Surg. 2015 Mar;47(3):550-5. doi: 10.1093/ejcts/ezu227. Epub 2014 Jun 3.
4
Prognostic and predictive role of epidermal growth factor receptor mutation in recurrent pulmonary adenocarcinoma after curative resection.表皮生长因子受体突变在根治性切除术后复发性肺腺癌中的预后及预测作用
Eur J Cardiothorac Surg. 2015 Mar;47(3):556-62. doi: 10.1093/ejcts/ezu177. Epub 2014 Apr 22.
5
The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.EGFR 突变状态对Ⅰ期非小细胞肺癌患者术后结局的影响。
Ann Thorac Surg. 2013 Sep;96(3):962-8. doi: 10.1016/j.athoracsur.2013.05.091. Epub 2013 Aug 8.
6
The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.表皮生长因子受体基因突变的存在不是非小细胞肺癌手术后长期预后的一个预测因素。
J Thorac Oncol. 2013 Feb;8(2):171-8. doi: 10.1097/JTO.0b013e318277a3bb.
7
Epidermal growth factor receptor mutation and treatment outcome of mediastinoscopic N2 positive non-small cell lung cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery.新辅助放化疗后手术治疗纵隔镜 N2 阳性非小细胞肺癌患者的表皮生长因子受体突变与治疗结果。
Lung Cancer. 2013 Mar;79(3):300-6. doi: 10.1016/j.lungcan.2012.11.010. Epub 2012 Dec 21.

Biomarkers in the era of individualized medicine.

作者信息

Kang Chang Hyun

机构信息

Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.

出版信息

J Thorac Dis. 2017 Jun;9(6):1453-1454. doi: 10.21037/jtd.2017.05.55.

DOI:10.21037/jtd.2017.05.55
PMID:28740656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5506155/
Abstract
摘要